Back to search

Article

Ascites-Derived Organoids for Prediction of Treatment Response and Clinical Management in Ovarian Cancer: A Case Report

2026-05-20

Abstract excerpt

<h4>Introduction</h4> High grade serous ovarian cancer patients initially respond to platinum-based chemotherapy but usually relapse within two years and ultimately develop therapy resistance. Management of response and effective clinical decisions are currently based on nonspecific biomarkers and limited imaging techniques, illustrating the clear clinical need for reliable predictors of response. <h4>Method</h4>...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
1adad2aa-71d2-590b-9910-de002f6ed11d
DOI
10.64898/2026.05.13.26352440
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Ascites-Derived Organoids for Prediction of Treatment Response and Clinical Management in Ovarian Cancer: A Case ReportDOI 10.64898/2026.05.13.26352440
Longitudinal Prediction of Drug Response in High-Grade Serous Ovarian Cancer Organoid Cultures Aligning with Clinical ResponsesSemantic proximity
Patient-Derived Organoids Functionally Stratify Epithelial Ovarian Cancer into Clinically Relevant Chemotherapy Response PhenotypesSemantic proximity
A platform for efficient establishment and drug-response profiling of high-grade serous ovarian cancer organoidsSemantic proximity
Comprehensive drug efficacy data for mucinous ovarian carcinoma using a novel and extensive biobank of patient-derived organoid modelsSemantic proximity
A platform for efficient establishment, expansion and drug response profiling of high-grade serous ovarian cancer organoidsSemantic proximity
Organoids serve as viable <i>in vitro</i> model for functional precision medicine for mesonephric-like adenocarcinoma of the ovarySemantic proximity
Patient-Derived Ovarian Cancer Organoids Mimic Clinical Response and Exhibit Heterogeneous Inter- and Intrapatient Drug ResponsesSemantic proximity
Organoid Models Established from Primary Tumors and Patient-Derived Xenograft Tumors Reflect Platinum Sensitivity of Ovarian Cancer PatientsSemantic proximity
In vitro drug testing using patient-derived ovarian cancer organoidsSemantic proximity
Generation of an in vitro 3D multicellular culture model of ovarian high-grade serous carcinomaSemantic proximity
Developing patient-derived organoids to predict PARP inhibitor response and explore resistance overcoming strategies in ovarian cancerSemantic proximity
Exploring the tumor micro-environment in ovarian cancer histotypes and tumor sitesSemantic proximity
Select a neighboring publication to make it the new centre.